X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
oncology (7) 7
aged (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cancer (5) 5
chemotherapy (5) 5
index medicus (5) 5
capecitabine (4) 4
clinical trials (4) 4
female (4) 4
fluorouracil - administration & dosage (4) 4
hematology, oncology and palliative medicine (4) 4
male (4) 4
middle aged (4) 4
research (4) 4
adult (3) 3
aged, 80 and over (3) 3
chemoradiotherapy (3) 3
colorectal cancer (3) 3
disease progression (3) 3
kaplan-meier estimate (3) 3
metastasis (3) 3
multicenter (3) 3
oncology, experimental (3) 3
organoplatinum compounds - administration & dosage (3) 3
radiotherapy (3) 3
surgery (3) 3
adjuvant treatment (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
cancer therapies (2) 2
carcinoma (2) 2
chemoradiation (2) 2
chemotherapy, adjuvant (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - mortality (2) 2
colorectal neoplasms - pathology (2) 2
combination (2) 2
fluorouracil - therapeutic use (2) 2
germany (2) 2
iii trial (2) 2
intention to treat analysis (2) 2
medical informatics (2) 2
medicine & public health (2) 2
mrc cr07 (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
oxaliplatin (2) 2
radiation (2) 2
rectal neoplasms - pathology (2) 2
rectal neoplasms - therapy (2) 2
studies (2) 2
survival (2) 2
time factors (2) 2
1st-line treatment (1) 1
5-fluorouracil (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - therapy (1) 1
adjuvant chemotherapy (1) 1
age factors (1) 1
angiogenesis (1) 1
angiogenesis inducing agents - biosynthesis (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
antigens (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
bevacizumab - adverse effects (1) 1
bevacizumab - therapeutic use (1) 1
biochemistry (1) 1
biological markers (1) 1
biomarkers (1) 1
biometry (1) 1
blood (1) 1
bone neoplasms - drug therapy (1) 1
bone neoplasms - secondary (1) 1
cancer patients (1) 1
capecitabine - adverse effects (1) 1
capecitabine - therapeutic use (1) 1
capox (1) 1
carcinoembryonic antigen (1) 1
care and treatment (1) 1
cell biology (1) 1
cell line (1) 1
cell transformation, neoplastic - metabolism (1) 1
chemoradiotherapy, adjuvant - adverse effects (1) 1
chemoradiotherapy, adjuvant - mortality (1) 1
chemotherapy-induced neutropenia (1) 1
cisplatin (1) 1
clinical radiotherapeutic studies (1) 1
clinical trials, phase ii as topic (1) 1
clinical trials, phase iii as topic (1) 1
colon-cancer (1) 1
combined modality therapy (1) 1
complications and side effects (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
dermatology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1355 - 1369
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 979 - 989
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 679 - 687
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2019, Volume 145, Issue 8, pp. 2282 - 2291
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 6/2012, Volume 30, Issue 3, pp. 1184 - 1192
Journal Article
Journal Article
Plasma Therapy and Transfusion Technology, ISSN 0278-6222, 1987, Volume 8, Issue 4, pp. 351 - 354
As an alternative technique to density-gradient separation, we studied the preparation of red blood cell (RBC)-depleted marrow mononuclear cells (MNC) by... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.